General MedicationsINJECTIONGeneric
NETROMYCIN
NETILMICIN SULFATE
Standard Dose
EQ 10MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview NETROMYCIN is listed in Drugs@FDA under application 050544 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient NETILMICIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 10MG BASE/ML Sponsor SCHERING Submission history Latest submission status date: 1998-01-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview NETROMYCIN is listed in Drugs@FDA under application 050544 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient NETILMICIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 10MG BASE/ML Sponsor SCHERING Submission history Latest submission status date: 1998-01-13 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.